Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Haematol ; 188(5): 661-673, 2020 03.
Article in English | MEDLINE | ID: mdl-31573078

ABSTRACT

Rituximab is a standard treatment for non-Hodgkin diffuse large B-cell (DLBCL) and follicular (FL) lymphomas. A subcutaneous formulation was developed to improve the resource use of intravenous rituximab, with comparable efficacy and safety profiles except for increased administration-related reactions (ARRs). MabRella was a phase IIIb trial to assess the safety of switching from intravenous to subcutaneous administration of rituximab during first-line induction/maintenance for DLBCL or FL, focusing on ARRs. Efficacy, satisfaction and quality of life were also assessed. Patients received subcutaneous rituximab plus standard induction chemotherapy for DLBCL or FL for 4-7 cycles, and/or every 2 months maintenance monotherapy for FL for 6-12 cycles. The study included 140 patients: DLBCL, n = 29; FL, n = 111. Ninety-five percent of patients experienced adverse events, reaching grade ≥3 in 38·6% and were serious in 30·0%. AARs occurred in 48·6%, mostly (84·9%) at the injection site, with only 2·1% of patients reaching grade 3. The end-of-induction complete/unconfirmed complete response rate was 69·6%. After a median follow-up of 33·5 months, median disease-/event-/progression-free and overall survivals were not attained. The Rituximab Administration Satisfaction Questionnaire showed improvements in overall satisfaction and the EuroQoL-5D a good quality-of-life perception at induction/maintenance end. Therefore, switching to subcutaneous rituximab showed no new safety issues and maintained efficacy with improved satisfaction and quality of life.


Subject(s)
Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/mortality , Quality of Life , Rituximab/administration & dosage , Safety , Administration, Intravenous , Adolescent , Adult , Aged , Aged, 80 and over , Disease-Free Survival , Female , Humans , Infusions, Subcutaneous , Male , Middle Aged , Rituximab/adverse effects , Spain/epidemiology , Survival Rate
2.
Ticks Tick Borne Dis ; 7(5): 983-987, 2016 07.
Article in English | MEDLINE | ID: mdl-27215620

ABSTRACT

Crimean-Congo hemorrhagic fever virus (CCHFV) was detected in Spain in 2010. The presence of CCHFV in Hyalomma marginatum ticks from migratory birds passing through Morocco during the spring migration strengthened the hypothesis of the arrival of infected ticks transported by birds to the Iberian Peninsula. Furthermore, Hyalomma species are vectors of bacterial infections such as spotted fever rickettsioses. CCHFV and Rickettsia were screened in Hyalomma ticks from Spain attached to patients (n=12) and birds (n=149). In addition, Rickettsia was investigated in 52 Hyalomma ticks from Morocco (previously reported as CCHFV-infected). No sample collected in Spain showed an infection with CCHFV. Two ticks removed from patients (16.7%), as well as 47 (31.5%) and 4 (7.7%) from birds, collected in Spain and Morocco respectively, were infected with Rickettsia aeschlimannii. Rickettsia sibirica subsp. mongolitimonae was also found in 2 ticks from birds collected in Spain (1.3%). The risk of CCHFV-infected ticks attached to migratory birds to reach the North of Spain is low. This study corroborates the presence of R. aeschlimannii in Spain and Morocco, and supports that H. marginatum can be a potential vector of R. sibirica subsp. mongolitimonae in the Iberian Peninsula.


Subject(s)
Arachnid Vectors/microbiology , Arachnid Vectors/virology , Hemorrhagic Fever Virus, Crimean-Congo/genetics , Ixodidae/microbiology , Ixodidae/virology , Rickettsia/genetics , Animal Migration , Animals , Bird Diseases/microbiology , Bird Diseases/parasitology , Birds/microbiology , Birds/parasitology , Birds/virology , Hemorrhagic Fever Virus, Crimean-Congo/isolation & purification , Humans , Morocco/epidemiology , Polymerase Chain Reaction , Rickettsia/isolation & purification , Spain/epidemiology , Tick Bites , Tick Infestations/parasitology , Tick Infestations/veterinary , Tick-Borne Diseases
3.
Mar Environ Res ; 87-88: 19-25, 2013.
Article in English | MEDLINE | ID: mdl-23541603

ABSTRACT

Stable isotopes analyses (SIAs) are an efficient tool to obtain a general insight into the diet of generalist consumers, such as the Yellow-legged Gull (Larus michahellis). Here we analysed δ(13)C, δ(15)N and δ(34)S values in feathers of chicks and adults, and used Bayesian triple-isotope mixing models to reconstruct the diet of a Yellow-legged Gull population breeding in the southeastern Bay of Biscay. Questions to test were (1) whether adults and chicks rely on different feeding resources during breeding period; (2) whether there is a seasonal foraging effect involving a higher proportion of refuse food in winter compared to summer, and (3) the magnitude of the annual variation in diet. Prey consumption differed between colonies, among years, and also varied slightly between seasons, and this was mainly due to a differential use of prey of marine origin. However, diet did not differ between age classes. These results suggest a relatively monotonous diet with only slight variations from year to year, seasonally and at a local geographic scale.


Subject(s)
Charadriiformes/physiology , Diet , Feeding Behavior , Nutritional Status , Animals , Bayes Theorem , Carbon Isotopes/metabolism , Charadriiformes/growth & development , Environmental Monitoring , Feathers/chemistry , Nitrogen Isotopes/metabolism , Seasons , Spain , Sulfur Isotopes/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...